Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.78 |
| ▸ | LMNA | P02545 | 1/20 | 0.78 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.78 |
| ▸ | FAAH | O00519 | 3/20 | 0.50 |
| ▸ | TSHR | P16473 | 3/20 | 0.48 |
| ▸ | MEN1 | O00255 | 1/20 | 0.46 |
| ▸ | MAPT | P10636 | 1/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.46 |
| ▸ | ATM | Q13315 | 1/20 | 0.46 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.46 |
| ▸ | NAAA | Q02083 | 1/20 | 0.44 |
| ▸ | DGKA | P23743 | 1/20 | 0.44 |
| ▸ | CES2 | O00748 | 2/20 | 0.43 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.43 |
| ▸ | MGAM | O43451 | 1/20 | 0.43 |
| ▸ | GAA | P10253 | 1/20 | 0.43 |
| ▸ | SI | P14410 | 1/20 | 0.43 |
| ▸ | MGAM2 | Q2M2H8 | 1/20 | 0.43 |
| ▸ | CES1 | P23141 | 1/20 | 0.43 |
| ▸ | SOAT1 | P35610 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hexane SCHEMBL10002813 | 1.00 | ALDH1A1 (0.78) | ALDH1A1LMNAHSD17B10FAAHTSHR | |
| Hexane SCHEMBL318366 | 1.00 | ALDH1A1 (0.78) | ALDH1A1LMNAHSD17B10FAAHTSHR | |
| Hexane SCHEMBL15769141 | 1.00 | ALDH1A1 (0.78) | ALDH1A1LMNAHSD17B10FAAHTSHR | |
| Hexane SCHEMBL514605 | 1.00 | ALDH1A1 (0.78) | ALDH1A1LMNAHSD17B10FAAHTSHR | |
| Hexane SCHEMBL301207 | 1.00 | ALDH1A1 (0.78) | ALDH1A1LMNAHSD17B10FAAHTSHR | |
| Hexane SCHEMBL637278 | 1.00 | ALDH1A1 (0.78) | ALDH1A1LMNAHSD17B10FAAHTSHR | |
| Hexane SCHEMBL4960168 | 1.00 | ALDH1A1 (0.78) | ALDH1A1LMNAHSD17B10FAAHTSHR | |
| Hexane SCHEMBL94686 | 1.00 | ALDH1A1 (0.78) | ALDH1A1LMNAHSD17B10FAAHTSHR | |
| Hexane SCHEMBL6720430 | 1.00 | ALDH1A1 (0.78) | ALDH1A1LMNAHSD17B10FAAHTSHR | |
| Hexane SCHEMBL4897173 | 1.00 | ALDH1A1 (0.78) | ALDH1A1LMNAHSD17B10FAAHTSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1016 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240239778-A1 | GRISEOFULVIN COMPOUND AND PHARMACEUTICAL USE THEREOF | DAIICHI SANKYO COMPANY, LIMITED (JP) | 2024-07-18 | — | — | US | disclosed |
| EP-3634966-B1 | COMPOUNDS USEFUL IN INHIBITING HUMAN TREFOIL FACTOR 3 | NAT UNIV SINGAPORE (SG) | 2024-06-05 | — | — | EP | disclosed |
| US-11993593-B2 | Griseofulvin compound and pharmaceutical use thereof | DAIICHI SANKYO COMPANY, LIMITED (JP) | 2024-05-28 | — | — | US | disclosed |
| WO-2024107076-A1 | PROCATALYST FOR OLEFIN POLYMERIZATION, METHOD FOR PREPARATION THEREOF | PUBLIC JOINT STOCK COMPANY "SIBUR HOLDING" (PJSC "SIBUR HOLDING") (RU) | 2024-05-23 | — | — | WO | disclosed |
| WO-2024107086-A1 | PROCATALYST FOR OLEFIN POLYMERIZATION AND USE THEREOF | PUBLIC JOINT STOCK COMPANY "SIBUR HOLDING" (PJSC "SIBUR HOLDING") (RU) | 2024-05-23 | — | — | WO | disclosed |
| CN-118047768-A | Oligostat analogue and antiviral application thereof | 华中农业大学 | 2024-05-17 | — | — | CN | disclosed |
| US-11946910-B2 | Triazolinedione adduct, method for producing triazolinedione adduct, method for producing ene compound, and method for analyzing ene compound | TOKUYAMA CORPORATION (JP) | 2024-04-02 | — | — | US | disclosed |
| CN-112368284-B | Electrochromic compound, electrochromic composition and electrochromic element | 株式会社理光 | 2024-03-08 | — | — | CN | disclosed |
| US-11859131-B2 | Electrochromic compound, electrochromic composition, and electrochromic element | RICOH COMPANY, LTD. (JP) | 2024-01-02 | — | — | US | disclosed |
| CN-112218868-B | Triazolinedione adducts, process for producing the same, process for producing alkylene compounds, and analytical method | 株式会社德山 | 2023-12-08 | — | — | CN | disclosed |
| US-4737513-A | PESTICIDES | ROUSSEL UCLAF (FR) | 1988-04-12 | — | — | US | disclosed |
| US-4701449-A | Novel 10-substituted steroids and their use in the induction of aldosterone antagonistic activity | ROUSSEL UCLAF (FR) | 1987-10-20 | — | — | US | disclosed |
| CN-86106242-A | 2-sulphomethyl-replacement-1,4-dihydropyridine, its manufacture method and the pharmaceutical composition that contains these compounds | — | 1987-05-13 | — | — | CN | disclosed |
| US-4628120-A | REARRANGEMENTS USING ORGANOALUMINUM COMPOUNDS | TOYO STAUFFER CHEMICAL CO., LTD. (JP) | 1986-12-09 | — | — | US | disclosed |
| EP-0122779-B1 | PRODUCTION OF OPTICALLY ACTIVE CYCLOPENTENOLONES | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1986-07-23 | — | — | EP | disclosed |
| US-4552703-A | Production of optically active cyclopentenolones | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1985-11-12 | — | — | US | disclosed |
| US-4540698-A | CONTROL OF PLANT DISEASES | MITSUI TOATSU CHEMICALS, INCORPORATED (JP) | 1985-09-10 | — | — | US | disclosed |
| EP-0122779-A1 | Production of optically active cyclopentenolones | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1984-10-24 | — | — | EP | disclosed |
| US-4374979-A | Regiospecific synthesis of anthracyclinone compounds such as daunomycinone | THE UNIVERSITY OF KANSAS ENDOWMENT ASSOCIATION (US) | 1983-02-22 | — | — | US | disclosed |
| EP-0063945-A1 | Process for the regiospecific synthesis of anthracyclinone compounds such as daunomycinone | THE UNIVERSITY OF KANSAS (US) | 1982-11-03 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11946910-B2 | Triazolinedione adduct, method for producing triazolinedione adduct, method for producing ene compound, and method for analyzing ene compound | NR2E1, AR, NR5A2 | ALDH1A1 219/4885LMNA 3288/4885HSD17B10 266/4885 |
| US-20240239778-A1 | GRISEOFULVIN COMPOUND AND PHARMACEUTICAL USE THEREOF | ACBD3, NR3C1, GRN | ALDH1A1 1113/4885LMNA 3783/4885HSD17B10 199/4885 |
| US-11993593-B2 | Griseofulvin compound and pharmaceutical use thereof | ACBD3, GRN, C1S | ALDH1A1 1136/4885LMNA 3831/4885HSD17B10 195/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.